Selected research
Industry Research
DNA Synthesis Service Industry Research Report 2026
Market perspective
The global DNA Synthesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA Synthesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA Synthesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA Synthesis Service include Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Azenta Life Sciences, SBS Genetech and Bio Basic, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA Synthesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA Synthesis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Synthesis Service Market by Company
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
DNA Synthesis Service Segment by Type
Oligonucleotide Synthesis
Gene Synthesis
DNA Synthesis Service Segment by Application
Commercial
Academic Research
DNA Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA Synthesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oligonucleotide Synthesis
- Gene Synthesis
Applications
- Commercial
- Academic Research
Companies covered
- Genescript
- Thermo Fisher Scientific
- IDT
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Azenta Life Sciences
- SBS Genetech
- Bio Basic
- Twist Bioscience
- OriGene
- Bioneer
- Eton Bioscience
- Synbio Technologies
- Eurogentec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA Synthesis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oligonucleotide Synthesis
- 2.2.3 Gene Synthesis
- 2.3 DNA Synthesis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Academic Research
- 2.4 Assumptions and Limitations
3 DNA Synthesis Service Breakdown Data by Type
- 3.1 Global DNA Synthesis Service Historic Market Size by Type (2021-2026)
- 3.2 Global DNA Synthesis Service Forecasted Market Size by Type (2027-2032)
4 DNA Synthesis Service Breakdown Data by Application
- 4.1 Global DNA Synthesis Service Historic Market Size by Application (2021-2026)
- 4.2 Global DNA Synthesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA Synthesis Service Market Perspective (2021-2032)
- 5.2 Global DNA Synthesis Service Growth Trends by Region
- 5.2.1 Global DNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA Synthesis Service Historic Market Size by Region (2021-2026)
- 5.2.3 DNA Synthesis Service Forecasted Market Size by Region (2027-2032)
- 5.3 DNA Synthesis Service Market Dynamics
- 5.3.1 DNA Synthesis Service Industry Trends
- 5.3.2 DNA Synthesis Service Market Drivers
- 5.3.3 DNA Synthesis Service Market Challenges
- 5.3.4 DNA Synthesis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA Synthesis Service Players by Revenue
- 6.1.1 Global Top DNA Synthesis Service Players by Revenue (2021-2026)
- 6.1.2 Global DNA Synthesis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA Synthesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA Synthesis Service Head Office and Area Served
- 6.4 Global DNA Synthesis Service Players, Product Type & Application
- 6.5 Global DNA Synthesis Service Manufacturers Established Date
- 6.6 Global DNA Synthesis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA Synthesis Service Market Size (2021-2032)
- 7.2 North America DNA Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA Synthesis Service Market Size by Country (2021-2026)
- 7.4 North America DNA Synthesis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA Synthesis Service Market Size (2021-2032)
- 8.2 Europe DNA Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA Synthesis Service Market Size by Country (2021-2026)
- 8.4 Europe DNA Synthesis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Synthesis Service Market Size (2021-2032)
- 9.2 Asia-Pacific DNA Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA Synthesis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA Synthesis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA Synthesis Service Market Size (2021-2032)
- 10.2 South America DNA Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA Synthesis Service Market Size by Country (2021-2026)
- 10.4 South America DNA Synthesis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Synthesis Service Market Size (2021-2032)
- 11.2 Middle East & Africa DNA Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA Synthesis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA Synthesis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genescript
- 12.1.1 Genescript Company Information
- 12.1.2 Genescript Business Overview
- 12.1.3 Genescript Revenue in DNA Synthesis Service Business (2021-2026)
- 12.1.4 Genescript DNA Synthesis Service Product Portfolio
- 12.1.5 Genescript Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in DNA Synthesis Service Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific DNA Synthesis Service Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 IDT
- 12.3.1 IDT Company Information
- 12.3.2 IDT Business Overview
- 12.3.3 IDT Revenue in DNA Synthesis Service Business (2021-2026)
- 12.3.4 IDT DNA Synthesis Service Product Portfolio
- 12.3.5 IDT Recent Developments
- 12.4 Eurofins Genomics
- 12.4.1 Eurofins Genomics Company Information
- 12.4.2 Eurofins Genomics Business Overview
- 12.4.3 Eurofins Genomics Revenue in DNA Synthesis Service Business (2021-2026)
- 12.4.4 Eurofins Genomics DNA Synthesis Service Product Portfolio
- 12.4.5 Eurofins Genomics Recent Developments
- 12.5 DNA 2.0 (ATUM)
- 12.5.1 DNA 2.0 (ATUM) Company Information
- 12.5.2 DNA 2.0 (ATUM) Business Overview
- 12.5.3 DNA 2.0 (ATUM) Revenue in DNA Synthesis Service Business (2021-2026)
- 12.5.4 DNA 2.0 (ATUM) DNA Synthesis Service Product Portfolio
- 12.5.5 DNA 2.0 (ATUM) Recent Developments
- 12.6 BBI
- 12.6.1 BBI Company Information
- 12.6.2 BBI Business Overview
- 12.6.3 BBI Revenue in DNA Synthesis Service Business (2021-2026)
- 12.6.4 BBI DNA Synthesis Service Product Portfolio
- 12.6.5 BBI Recent Developments
- 12.7 Azenta Life Sciences
- 12.7.1 Azenta Life Sciences Company Information
- 12.7.2 Azenta Life Sciences Business Overview
- 12.7.3 Azenta Life Sciences Revenue in DNA Synthesis Service Business (2021-2026)
- 12.7.4 Azenta Life Sciences DNA Synthesis Service Product Portfolio
- 12.7.5 Azenta Life Sciences Recent Developments
- 12.8 SBS Genetech
- 12.8.1 SBS Genetech Company Information
- 12.8.2 SBS Genetech Business Overview
- 12.8.3 SBS Genetech Revenue in DNA Synthesis Service Business (2021-2026)
- 12.8.4 SBS Genetech DNA Synthesis Service Product Portfolio
- 12.8.5 SBS Genetech Recent Developments
- 12.9 Bio Basic
- 12.9.1 Bio Basic Company Information
- 12.9.2 Bio Basic Business Overview
- 12.9.3 Bio Basic Revenue in DNA Synthesis Service Business (2021-2026)
- 12.9.4 Bio Basic DNA Synthesis Service Product Portfolio
- 12.9.5 Bio Basic Recent Developments
- 12.10 Twist Bioscience
- 12.10.1 Twist Bioscience Company Information
- 12.10.2 Twist Bioscience Business Overview
- 12.10.3 Twist Bioscience Revenue in DNA Synthesis Service Business (2021-2026)
- 12.10.4 Twist Bioscience DNA Synthesis Service Product Portfolio
- 12.10.5 Twist Bioscience Recent Developments
- 12.11 OriGene
- 12.11.1 OriGene Company Information
- 12.11.2 OriGene Business Overview
- 12.11.3 OriGene Revenue in DNA Synthesis Service Business (2021-2026)
- 12.11.4 OriGene DNA Synthesis Service Product Portfolio
- 12.11.5 OriGene Recent Developments
- 12.12 Bioneer
- 12.12.1 Bioneer Company Information
- 12.12.2 Bioneer Business Overview
- 12.12.3 Bioneer Revenue in DNA Synthesis Service Business (2021-2026)
- 12.12.4 Bioneer DNA Synthesis Service Product Portfolio
- 12.12.5 Bioneer Recent Developments
- 12.13 Eton Bioscience
- 12.13.1 Eton Bioscience Company Information
- 12.13.2 Eton Bioscience Business Overview
- 12.13.3 Eton Bioscience Revenue in DNA Synthesis Service Business (2021-2026)
- 12.13.4 Eton Bioscience DNA Synthesis Service Product Portfolio
- 12.13.5 Eton Bioscience Recent Developments
- 12.14 Synbio Technologies
- 12.14.1 Synbio Technologies Company Information
- 12.14.2 Synbio Technologies Business Overview
- 12.14.3 Synbio Technologies Revenue in DNA Synthesis Service Business (2021-2026)
- 12.14.4 Synbio Technologies DNA Synthesis Service Product Portfolio
- 12.14.5 Synbio Technologies Recent Developments
- 12.15 Eurogentec
- 12.15.1 Eurogentec Company Information
- 12.15.2 Eurogentec Business Overview
- 12.15.3 Eurogentec Revenue in DNA Synthesis Service Business (2021-2026)
- 12.15.4 Eurogentec DNA Synthesis Service Product Portfolio
- 12.15.5 Eurogentec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst